Author, Year of Study | Location | Test Methods | Prevalence of C. difficile |
---|---|---|---|
Kim, 1981 [37] | U.S. | Culture + cytotoxicity assay | 21% culture +, 14% toxin + |
Blakey, 1982 [31] | Australia | Culture | 0–35% culture +a |
Donta, 1982 [18] | U.S. | Cytotoxicity assay | 54.9% toxin + |
Sherertz, 1982 [25] | U.S. | Culture | 59% culture + |
Malamou-Ladas, 1983 [39] | England | Culture | 54% culture + |
Al-Jumaili, 1984 [13] | England | Culture + cytotoxicity assay | 71% culture +, 45% toxin + |
Lishman, 1984 [38] | England | Culture + cytotoxicity assay | 78% culture +, 67% toxin + |
Phua, 1984 [40] | England | Culture + cytotoxicity assay | 21% culture +, 0% toxin + |
Zedd, 1984 [42] | U.S. | Culture | 41% culture + |
Cardines, 1988 [32] | Italy | Culture + cytotoxicity assay + PAGEb | 63% culture +, 0% toxin + (per cytotoxicity assay), 16% toxigenic strain + (per PAGE) |
el-Mohandes, 1993 [34] | U.S. | Culture + cytotoxicity assay | 15–33% culture +, 71–100% toxin +c |
Kato, 1994 [36] | Japan | Culture + PCR for toxins A and B | 61% culture +, 6% toxin +d |
Tina, 1994 [41] | Italy | Culture + EIA for toxins A and B | 43.6% culture +, 31.2% toxin + |
Enad, 1997 [19] | U.S. | EIA for toxin A | 52% EIA + |
Alfa, 2002 [30] | Canada | PCR for C. difficile 16S gene | 21% C. difficile 16S gene + |
Chang, 2012 [33] | Korea | PCR for C. difficile 16S gene + PCR for toxins A and B | 34.7–53.1% C. difficile 16S gene+e 23.5–30.8% toxin + |
Ferraris, 2012 [35] | France | PCR for C. difficile 16S gene | 42.1% C. difficile 16S gene+ |
Faden, 2015 [20] | U.S. | EIA GDH Ag/toxins A/B C. difficile culture | 25.7% +f |